Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss - Scorecard - MDSpire
Clinical Scorecard: Comparative Efficacy and Predictive Factors of Customized Mixed Acoustic Therapy for Chronic Tinnitus in Patients with and without Hearing Impairment
At a Glance
Category
Detail
Condition
Chronic Tinnitus
Key Mechanisms
Personalized mixed acoustic therapy combining narrow-band noise and music.
Target Population
Patients aged 40-60 years with chronic tinnitus, stratified by hearing loss status.
Care Setting
Prospective observational cohort study.
Key Highlights
Both HL and NHL groups showed comparable improvements in tinnitus frequency and loudness after 3 months.
NHL group had significantly greater reductions in HAMA and THI scores.
Independent predictors of favorable outcomes included NHL status, female sex, and lower baseline PSQI and HAMA scores.
Guideline-Based Recommendations
Diagnosis
Chronic subjective tinnitus diagnosed according to the 2014 clinical practice guideline of the American Academy of Otolaryngology–Head and Neck Surgery.
Management
Personalized mixed acoustic therapy as a non-invasive treatment option.
Monitoring & Follow-up
Regular assessment of tinnitus frequency, loudness, and psychological scales (HAMA, HAMD, PSQI, THI).
Risks
Exclusion of patients currently using psychotropic medication or participating in other interventional studies.
Patient & Prescribing Data
111 patients with chronic tinnitus (51 HL, 60 NHL).
Mixed acoustic therapy improves tinnitus perception and sleep quality, with greater psychological benefits in NHL patients.
Clinical Best Practices
Utilize bilateral subjective acoustic assessment for tinnitus evaluation.
Consider audiometric and psychometric phenotypes for personalized tinnitus management.
